SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZSP, Genzyme Surgical Products -- Ignore unavailable to you. Want to Upgrade?

To: Tom Hua who wrote (47)2/17/2000 9:25:00 PM
From: Biomaven  Read Replies (2) | Respond to of 55
 
Tom,

I thought biotech stocks can only go up these days

Unfortunately that "Surgical" in the name is a dead giveaway. Makes it too obvious to the newbies that the company doesn't have anything to do with genomics. <g>

Peter



To: Tom Hua who wrote (47)3/8/2000 9:10:00 PM
From: Mad2  Read Replies (1) | Respond to of 55
 
Have you figured out the BXM angle yet?
by my calc's GZSP should be worth 20-22 bucks a share based on the 37 cash offer on BXM.
The large number of shorts in BXM and downgrades have me questioning whats going on.
Mad2


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News